4.6 Article

Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-beta 1 Epithelial Mesenchymal Transition

期刊

CELLS
卷 9, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/cells9010083

关键词

hepatocellular carcinoma (HCC); tumor microenvironment (TME); 3-dimensional (3D) platform; 3D ECM scaffolds; decellularized human liver; decellularized extracellular matrix (dECM); proteomics; hepatocellular carcinoma cells; Transforming growth factor beta1 (TGF-beta 1); tissue engineering

资金

  1. Royal Free Charity
  2. UCL NIHR Biomedical Research Centre
  3. PSC Partners
  4. European Association for the Study of the Liver (EASL)
  5. Great Ormond Street Hospital Charity
  6. MRC
  7. Welcome Trust
  8. UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme [NIHR-RP-2014-04-046]
  9. ERC [282051]

向作者/读者索取更多资源

An altered liver microenvironment characterized by a dysregulated extracellular matrix (ECM) supports the development and progression of hepatocellular carcinoma (HCC). The development of experimental platforms able to reproduce these physio-pathological conditions is essential in order to identify and validate new therapeutic targets for HCC. The aim of this work was to validate a new in vitro model based on engineering three-dimensional (3D) healthy and cirrhotic human liver scaffolds with HCC cells recreating the micro-environmental features favoring HCC. Healthy and cirrhotic human livers ECM scaffolds were developed using a high shear stress oscillation-decellularization procedure. The scaffolds bio-physical/bio-chemical properties were analyzed by qualitative and quantitative approaches. Cirrhotic 3D scaffolds were characterized by biomechanical properties and microarchitecture typical of the native cirrhotic tissue. Proteomic analysis was employed on decellularized 3D scaffolds and showed specific enriched proteins in cirrhotic ECM in comparison to healthy ECM proteins. Cell repopulation of cirrhotic scaffolds highlighted a unique up-regulation in genes related to epithelial to mesenchymal transition (EMT) and TGF beta signaling. This was also supported by the presence and release of higher concentration of endogenous TGF beta 1 in cirrhotic scaffolds in comparison to healthy scaffolds. Fibronectin secretion was significantly upregulated in cells grown in cirrhotic scaffolds in comparison to cells engrafted in healthy scaffolds. TGF beta 1 induced the phosphorylation of canonical proteins Smad2/3, which was ECM scaffold-dependent. Important, TGF beta 1-induced phosphorylation of Smad2/3 was significantly reduced and ECM scaffold-independent when pre/simultaneously treated with the TGF beta-R1 kinase inhibitor Galunisertib. In conclusion, the inherent features of cirrhotic human liver ECM micro-environment were dissected and characterized for the first time as key pro-carcinogenic components in HCC development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据